Methotrexate, Vinblastine, Epidoxorubicin, and Bleomycin as Second-Line Chemotherapy for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Autor: Roberto Valenza, Salvatore Restivo, Nicola Gebbia, Riccardo Speciale, G Cannata, Giovanni Spadafora, Vittorio Gebbia, Nicolò Borsellino, Federico Ingria, Antonio Testa

Publikováno v: ORL. 56:279-282

Thirty evaluable patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck region previously treated with cisplatin-based chemotherapy were treated with a combination of methotrexate, vinblastine, epidoxorubicin, and bleo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06dd8971171c23e5b06fee86c9a59809
https://doi.org/10.1159/000276674

Contents, Vol. 50, 1993

Autor: Giuseppe Ricciardi, P.F. Conte, Masaharu Yoshihara, J. Limon, T. Jørgensen, B.E. Christensen, Sachio Fushida, Motofumi Yoshida, Ikuo Takahashi, Keizo Sugimachi, Koji Sumii, J. Schädelin, Claudio Rolim Teixeira, Enrico Colli, H. Hasle, D. Gardiner, Masahito Sugimura, Vittorio Gebbia, Salvatore Restivo, S. Barni, H. Birgens, M.A. Nagai, C.H. Wilder-Smith, A. Drivsholm, Yasunori Emi, Demetrios Minaretzis, M. Hrženjak, O.H.G. Wilder-Smith, Giuseppe Del Favero, Antonio Testa, M.M. Brentani, N.E. Hansen, Fabio Parazzini, Daniel Mordochovich, G. Seitz, Michael D. Melekos, L.A. Marques, G Cannata, M.M. Hansen, P. Lissoni, P.M. Suter, A. Borgeat, Yutaka Yonemura, Fumio Shimamoto, C Ferrara, M. Boogaerts, Daniela Basso, N. Blin, N.A. Peterslund, Elise Kokron, Mario Plebani, V. Jønsson, I. Kardaś, Noboru Konishi, Giovanni Spadafora, Yoshio Hiasa, Luca Tozzi, N. Žarković, Walter Paukovits, Lucia Desser, M. Forni, G.J.M. Maestroni, Tetsuya Kusumoto, S. Taesch, Francesco Mangano, Paola Fogar, M. Jurin, Bosco Lopez Saez, Z. Ilić, A. Rubagotti, Hiroto Nishioka, Roberto Valenza, J. Nikoskelainen, A. Ardizzoia, Marco Scatigna, Shinji Tanaka, Giuseppe Zerillo, Tamara Meggiato, Alexander Rehberger, Nicola Gebbia, Kouichiro Tsugawa, C. Welter, A. Niezabitowski, Gianfranco Cupido, A. Ferrant, Yoshiteru Kitahori, Diana Rinkevitch, Yehudith Ben-Arieh, Isao Hayashi, Federico Ingria, A. Conti, Ken Haruma, G. Gardin, Khalida P. Salim, Lael Best, Shunji Kohnoe, Shad S. Akhtar, I. Sklenar, G. Verhoef, D. Aravantinos, Goro Kajiyama, Walter Markiewicz, G. Schiffman, K.D. Christensen, Carmelo Barbaccia, R. Rosso, G. Bertelli, Angelo Burlina, G. Tancini, Stylianos Michalas, Zareefa A. Bano, G. Towse, Rebsdorf Pedersen, H. Torloni, Christina Tsionou, P. Pronzato, Antonis Keramopoulos, Yoshihiko Maehara, J. Ryś, Senra Varela, F. Rovelli, R. Lahtinen

Publikováno v: Oncology. 50:I-VI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c0a1cf8df5397552c9bdce4fb5e699d0
https://doi.org/10.1159/000227216

Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancer

Autor: Giuseppe Zerillo, Federico Ingria, G Cannata, Salvatore Restivo, Antonio Testa, Nicola Gebbia, Gianfranco Cupido, Giovanni Spadafora, Roberto Valenza, Vittorio Gebbia, Carmelo Barbaccia, Calogero Cipolla

Publikováno v: Medical oncology and tumor pharmacotherapy. 9(4)

Twenty-two patients with advanced head and neck carcinoma were treated with 5FU 400 mg-2 m-1 week and folinic acid 500 mg m-2 week-1 plus CDDP in escalating doses from 20 to 40 mg m-2 week-1 without forced diuresis. Reduced gluthatione at the dose of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20a4be26c0583a050653dda3a85eaba
https://pubmed.ncbi.nlm.nih.gov/1342059